Flucytosine and You

This project is an investigation into how kidney failure affects the pharmacokinetics of flucytosine. There are three main parts to this project: the application (what the problem is), the algorithm (how we model the problem), and the architecture (how we use the model).


What is the problem?


How do we model it?


How do we run the model?


Run the model!

Extensions of the model

Sources and acknowledgements

Glossary of terms

Shodor homepage

Attention:This web site and model are not intended to replace the advice of a physician or pharmacist. Consult a physician or pharmacist for all information or guidance about prescription medications.

Written by Lauren Mauro, under the direction of Robert Gotwals of the Shodor Education Foundation
email us with questions or comments at lauren@shodor.org
June 17, 1998